It is also worth mentioning that prolonged expression of Nrf2 was shown to protect cancer cells by inducing the metabolism and efflux of chemotherapeutics, leading to both intrinsic and acquired chemoresistance to anti-cancer drugs, an effect that can be regarded as the "dark side" of Nrf2. The gene discussed is NFE2L2; the disease is cancer.